why now

AIDS Ark has been helping fund medication for people with HIV since 2002 out of a moral imperative to help those in need attain access to antiretroviral medication to fight the deadly virus. Though treatment was a controversial way to use funds to fight the epidemic at the time, AIDS Ark founder trustees had intuition and foresight to bring HAART treatment to the frontiers of the developing world.

In 2011, as part of an initiative hosted by the Copenhagen Consensus Center and the Rush Foundation to rethink priorities for the fight against HIV, Nobel laureates and governments in the developing world, informed by new research, rated antiretroviral treatment programmes as a top priority for intervention against HIV and AIDS because they help patients live productively over near-normal lifespans, while at the same time reducing the likelihood of further transmission of the virus.

With relationships already in place, AIDS Ark is leveraging its strong position to deliver on the new consensus for HIV/AIDS spending, with treatment now considered one of the highest priorities.

AIDS Ark’s continued efforts are especially important as larger organisations like The Global Fund and PEPFAR are having to cut funding.

Visit RethinkHIV.org to read about the latest research and consensus on HIV funding priorities.